AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Explore effective ways to make money and pay off debt. Boost your finances and achieve your goals with our actionable tips.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Arkansas plans to implement a SNAP candy-and-soda ban starting Wednesday, defying a federal court ruling that blocked...
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
Publicly traded crypto firms rose 23% in the first half of 2026 while crypto assets declined 36%, widening the gap to...
A dramatic seed-phrase leak led to a flurry of activity around seized wallets. This piece explores what happened, why...
Fresh insider purchases in three battered names point to growing belief that cash flow and demand visibility can rebo...
Jet fuel costs are climbing amid geopolitical tensions, prompting United Airlines to warn that airfares could rise as...
As U.S. rates linger near 4.4%, the VictoryShares ETF CDL is drawing attention for its ability to blend dividend inco...
A major eVTOL company completed a JFK-to-Manhattan flight in under 10 minutes as regulators widen state approvals. In...
Investors are turning to international dividend stocks to lift income and reduce reliance on U.S. mega-caps. A $350,0...
The 2027 COLA could lift benefits, but rising Medicare costs and hold-harmless rules mean many retirees may see littl...
NVIDIA has surged to the top of many investors' lists as AI demand accelerates. This highest-conviction stock right n...